Cargando…

Genomic landscape of extraordinary responses in metastatic breast cancer

Extreme responders to anticancer therapy are rare among advanced breast cancer patients. Researchers, however, have yet to investigate treatment responses therein on the whole exome level. We performed whole exome analysis to characterize the genomic landscape of extreme responders among metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Sun Min, Kim, Eunyoung, Jung, Kyung Hae, Kim, Sora, Koo, Ja Seung, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Park, Byoung Woo, Cho, Young Up, Kim, Ji Ye, Paik, Soonmyung, Kwon, Nak-Jung, Kim, Gun Min, Kim, Ji Hyoung, Kim, Min Hwan, Jeon, Min Kyung, Kim, Sangwoo, Sohn, Joohyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035393/ https://www.ncbi.nlm.nih.gov/pubmed/33837242 http://dx.doi.org/10.1038/s42003-021-01973-x

Ejemplares similares

Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Park, Seho, et al.
Publicado: (2018)

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
por: Kim, Gun Min, et al.
Publicado: (2019)

Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication
por: Kim, Min Hwan, et al.
Publicado: (2015)

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
por: Moon, Yong Wha, et al.
Publicado: (2013)

Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
por: Park, Seho, et al.
Publicado: (2016)

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
por: Moon, Yong Wha, et al.
Publicado: (2017)

Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer
por: Kim, Seul-Gi, et al.
Publicado: (2023)

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
por: Kim, Chang Gon, et al.
Publicado: (2023)

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
por: Kim, Chang Gon, et al.
Publicado: (2016)

Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer
por: Park, Vivian Youngjean, et al.
Publicado: (2016)

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2021)

Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results
por: Park, Hyung Seok, et al.
Publicado: (2017)

Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
por: Park, Hyung Seok, et al.
Publicado: (2017)

External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
por: Lee, Byung Min, et al.
Publicado: (2018)

Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers
por: Park, Seho, et al.
Publicado: (2017)

Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography
por: Won, So Yeon, et al.
Publicado: (2021)

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
por: Pandey, Kamal, et al.
Publicado: (2019)

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers
por: Choi, Ji Soo, et al.
Publicado: (2017)

Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts
por: Park, Sunyoung, et al.
Publicado: (2022)

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy
por: Jung, Minkyu, et al.
Publicado: (2012)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
por: Lee, Seeyoun, et al.
Publicado: (2017)

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
por: Ji, Jung Hwan, et al.
Publicado: (2022)

An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier
por: Seo, Mi-kyoung, et al.
Publicado: (2020)

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)
por: Kim, Ji-Yeon, et al.
Publicado: (2019)

Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation: A Case Report
por: Kim, Hye Min, et al.
Publicado: (2017)

Veno-arterial extracorporeal membrane oxygenation for severe fever with thrombocytopenia syndrome with fulminant myocarditis: a case report
por: Kim, Uh. Jin, et al.
Publicado: (2021)

Morphological Features and Cold-Response Gene Expression in Mesophilic Bacillus cereus Group and Psychrotolerant Bacillus cereus Group under Low Temperature
por: Park, Kyung-Min, et al.
Publicado: (2021)

HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors
por: Choi, Ji Soo, et al.
Publicado: (2012)

Children with Heiner Syndrome: A Single-Center Experience
por: Lee, Ji Young, et al.
Publicado: (2021)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Influence of Pulse Type on Subcellular Selective Photothermolysis of Melanosomes in Adult Zebrafish Skin Following 1,064-nm, Q-switched, Nd:YAG Laser Irradiation: A Pilot Study
por: Yoo, Min Gun, et al.
Publicado: (2015)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

Antimicrobial Effect of Acetic Acid, Sodium Hypochlorite, and Thermal Treatments against Psychrotolerant Bacillus cereus Group Isolated from Lettuce (Lactuca sativa L.)
por: Park, Kyung-Min, et al.
Publicado: (2021)

Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
por: Kim, Hyung Sun, et al.
Publicado: (2016)

Coxsackievirus B Infection Is Highly Related with Missed Abortion in Korea
por: Hwang, Jung Hye, et al.
Publicado: (2014)

Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
por: Kim, Sung Kyoung, et al.
Publicado: (2021)

Antiviral Activities of High Energy E-Beam Induced Copper Nanoparticles against H1N1 Influenza Virus
por: Ha, Taesung, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
por: Hyun, Kyung-A, et al.
Publicado: (2016)

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
por: Kang, Jin Hyoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k2jhae5vd23r9q0mskqfmpoheh